Mind Matters
NIH reorganizes clinical trial funding system
Grace Morrison · November 14, 2026
NIH develops unified approach to clinical trial funding, streamlining submission guidelines for researchers with clinical trial funding.
01
02
03
04
05
AbbVie’s Maviret achieves 96% cure rate for acute hepatitis C but excludes key patient groups, raising access and efficacy concerns in real-world…
NIH develops unified approach to clinical trial funding, streamlining submission guidelines for researchers with clinical trial funding.
The FDA requires a new warning about vision loss for GLP-1 drugs after a review of clinical trials…
Compass Pathways has filed an FDA NDA for its psilocybin depression treatment, COMP360, after two Phase 3 trials…
Proteolysis-targeting chimeras face major formulation hurdles that may delay their approval. Learn about the challenges facing PROTAC drugs…
Insilico Medicine’s AI-designed TEAD inhibitor ISM6331 shows 18.2% response rate in mesothelioma patients, with 68.2% achieving disease control…
AbbVie’s Maviret achieves 96% cure rate for acute hepatitis C but excludes key patient groups, raising access and…
Moderna and Merck are seeking approval for intismeran autogene, a melanoma vaccine, after their November 6 earnings release,…
Trump pressures Europe to cut drug prices, while his administration delays new launches, as a March 2026 poll…
FDA approves Voceryq, the first DNA-based immunotherapy for HPV-driven recurrent respiratory papillomatosis (RRP), offering hope for patients avoiding…
Generic manufacturers may shift focus to reliability due to supply chain issues and price pressure affecting the industry.
